| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Steinman Lawrence is a Director at Pasithea Therapeutics Corp. with holdings across 2 companies. Recent SEC Form 4 filings include 3 buys and 4 sells.
Estimated insider holdings value: $509K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 28, 2025 | KTTA Pasithea Therapeutics Corp. | Director | Buy | 133,333 | $0.75 | $99,999.75 | +200.9% | -43.3% | - | |
| Dec 19, 2023 | BCAB Bioatla, Inc. | Director | Buy | 20,000 | $2.05 | $41,048.00 | +108.3% | +17.3% | -40.9% | |
| Jun 2, 2023 | KTTA Pasithea Therapeutics Corp. | Director | Buy | 30,000 | $0.43 | $12,930.00 | +2.3% | +51.4% | -31.8% | |
| Nov 2, 2021 | BCAB Bioatla, Inc. | Director | Sell | 450 | $30.00 | $13,500.00 | -2.4% | -68.1% | -78.5% | |
| Sep 15, 2021 | BCAB Bioatla, Inc. | Director | Sell | 450 | $36.82 | $16,569.00 | -2.3% | -43.7% | -76.8% | |
| Aug 16, 2021 | BCAB Bioatla, Inc. | Director | Sell | 450 | $40.60 | $18,270.00 | -2.3% | -32.0% | -70.3% | |
| Jul 15, 2021 | BCAB Bioatla, Inc. | Director | Sell | 450 | $38.29 | $17,230.50 | -2.2% | -27.3% | -88.9% |